1. Korean National Mental Health Center. National Mental Health Statistics;2021.
2. König H, König HH, Gallinat J, Lambert M, Karow A, Peth J, et al. Excess costs of mental disorders by level of severity. Soc Psychiatry Psychiatr Epidemiol. 2023; 58:973–985.
Article
3. The National Mental Health and Welfare Commission. The socioeconomic costs of the mental illness. National Mental Health Trends. 2019; 14:1–3.
4. O’Donoghue B, O’Connor K, Thompson A, McGorry P. The need for early intervention for psychosis to persist throughout the COVID-19 pandemic and beyond. Ir J Psychol Med. 2021; 38:214–219.
Article
5. Morgan VA, McGrath JJ, Jablensky A, Badcock JC, Waterreus A, Bush R, et al. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis. Psychol Med. 2014; 44:2163–2176.
Article
6. Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, et al. Initial severity of schizophrenia and efficacy of antipsychotics: Participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry. 2015; 72:14–21.
https://doi.org/10.1001/jamapsychiatry.2014.2127.
Article
7. Gaebel W, Riesbeck M, Wobrock T. Schizophrenia guidelines across the world: A selective review and comparison. Intl Rev Psychiatry. 2011; 4:379–387.
Article
8. Bach P. ACT with the Seriously Mentally Ill. In A Practical Guide to Acceptance and Commitment Therapy. NY: Springer;2004. p. 185–208.
9. Miner CR, Rosenthal RN, Hellerstein DJ. Prediction of Compliance with Outpatient Referral in Patients With Schizophrenia and Psychoactive Substance Use Disorders. Arch Gen Psychiatry. 1997; 8:706–712.
Article
10. Anthony WA. Recovery From Mental Illness: The Guiding Vision of the Mental Health Service System in the 1990s. Psychosoc Rehab J. 1993; 4:11–23.
Article
11. WHO Mental Health and Substance Use Team. Recovery and the right to health. WHO QualityRights Core training: mental health and social services. World Health Organization;2019.
12. Slade M, Williams J, Bird V, Leamy M, Le Boutillier C. Recovery grows up. J Ment Health. Informa Healthcare. 2012; 2:99–103.
13. Conradi HJ, Ormel J, De Jonge P. Symptom profiles of DSM-IVdefined remission, recovery, relapse, and recurrence of depression: the role of the core symptoms. Depress Anxiety. 2012; 29:638–645.
Article
14. Wunderink L, Sytema S, Nienhuis FJ, Wiersma D. Clinical recovery in first-episode psychosis. Schizophr Bull. 2009; 35:362–369.
Article
15. Bäckström M, Lund K, Eklund M. Exploring mediators of the recovery process over time among mental health service users, using a mixed model regression analysis based on cluster RCT data. BMC Psychiatry. 2020; 520:1–12.
Article
16. Jeong NR and Woo JH. Systematic Literature Review and Meta-analysis on Acceptance-Commitment Therapy for Psychotic Disorder Based on the Perspective of Recovery. J Rehab Psychol. 2021; 28:41–62.
17. Jagtap S, Romanowska S, Leibovitz T, Onno KA, Burhan AM, Best MW. Can cognitive remediation therapy be delivered remotely? A review examining feasibility and acceptability of remote interventions. Schizophr Res Cogn. 2022; 102238:1–7.
Article
18. Davies A, Mueller J. mHealth, eHealth and Related Term. In Developing medical apps and mHealth interventions: a guide for researchers, physicians and informaticians. NY: Springer;2020.
19. Lee SE, Shin H, Hur JW. mHealth for Mental Health in the COVID-19 Era. Kor J Clin Psychol. 2020; 39:325–354.
Article
20. Jeong NR, Kim EJ. Development and effects of mobile app-based Acceptance-Commitment Therapy for clinical outpatients with depressive symptoms. CBT in Kor. 2023; 23:177–200.
Article
21. Miralles I, Granell C, Díaz-Sanahuja L, van Woensel W, BretónLópez J, Mira A, et al. Smartphone apps for the treatment of mental disorders: Systematic review. JMIR mHealth and uHealth. 2020; 4:1–28.
Article
22. Kim H, Choi H, Han SM. The Internet-based CBT. Seoul: Hakjisa;2020.
23. Kuhn E, McGee-Vincent P. Using mobile Apps in mental health practice. In : Reger GM, editor. Technology and mental health: a clinician’s guide to improving outcomes. UK: Routledge/Taylor & Francis Group;2021. p. 56–74.
24. Wrzus C, Neubauer AB. Ecological Momentary Assessment: a Meta-Analysis on Designs, Samples, and Compliance Across Research Fields. Assessment. 2023; 30:825–846.
Article
25. Kwon S, Firth J, Joshi D, Torous J. Accessibility and availability of smartphone apps for schizophrenia. Schizophrenia. 2022; 1:1–15.
Article
26. Oh E, Gang M. Effect of Digital Health Interventions on Psychotic Symptoms among Persons with Severe Mental Illness in Community: A Systematic Review and Meta-Analysis. J Kor Acad Nurs. 2023; 53:69–86.
Article
27. Fulford D, Schupbach E, Gard DE, Mueser KT, Mow J. Do cognitive impairments limit treatment gains in a standalone digital intervention for psychosis? A test of the digital divide. Schizophr Res Cogn. 2022; 100244:1–6.
Article
28. Nassir Ghaemi S, Sverdlov O, Van Dam J, Campellone T, Gerwien R. A Smartphone-Based Intervention as an Adjunct to Standardof-Care Treatment for Schizophrenia: Randomized Controlled Trial. JMIR Form Res. 2022; 3:1–16.
Article
29. Gumley AI, Bradstreet S, Ainsworth J, Allan S, Alvarez-Jimenez M, Birchwood M, et al. Digital smartphone intervention to recognise and manage early warning signs in schizophrenia to prevent relapse: the EMPOWER feasibility cluster RCT. Health Technol Assess (Rockv). 2022; 27:1–173.
Article
30. Weintraub MJ, Ichinose MC, Zinberg J, Done M, Morgan-Fleming GM, Wilkerson CA, et al. App-enhanced transdiagnostic CBT for adolescents with mood or psychotic spectrum disorders. J Affect Disord. 2022; 311:319–326.
Article
31. Ben-Zeev D, Chander A, Tauscher J, Buck B, Nepal S, Campbell A, et al. A smartphone intervention for people with serious mental illness: Fully remote randomized controlled trial of CORE. J Med Internet Res. 2021; 11:1–16.
Article
32. Dabit S, Quraishi S, Jordan J, Biagianti B. Improving social functioning in people with schizophrenia-spectrum disorders via mobile experimental interventions: Results from the CLIMB pilot trial. Schizophr Res Cogn. 2021; 100211:1–10.
Article
33. Garety P, Ward T, Emsley R, Greenwood K, Freeman D, Fowler D, et al. Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia among People with Psychosis: A Randomized Clinical Trial. JAMA Psychiatry. 2021; 78:714–725.
Article
34. Haesebaert F, El Oussoul S, Pavard A, Fabre D, Cellard C, Magaud L, et al. PLAN-e-PSY, a mobile application to improve case management and patient’s functioning in first episode psychosis: Protocol for an open-label, multicentre, superiority, randomised controlled trial. BMJ Open. 2021; 9:1–11.
Article
35. Kidd SA, Feldcamp L, Adler A, Kaleis L, Wang W, Vichnevetski K, et al. Feasibility and outcomes of a multi-function mobile health approach for the schizophrenia spectrum: APP4Independence (A4I). PLoS One. 2019; 7:1–17.
Article
36. Steare T, Giorgalli M, Free K, Harju-Seppänen J, Akther S, Eskinazi M, et al. A qualitative study of stakeholder views on the use of a digital app for supported self-management in early intervention services for psychosis. BMC Psychiatry. 2021; 311:1–12.
Article
37. Krzystanek M, Krysta K, Borkowski M, Przybyło J, Pałasz A, et al. The effect of smartphone-based cognitive training on the functional/cognitive markers of schizophrenia: a one-year randomized study. J Clin Med. 2020; 9:1–12.
Article
38. Cullen BA, Rodriguez K, Eaton WW, Mojtabai R, Von Mach T, Ybarra ML. Clinical outcomes from the texting for relapse prevention (T4RP) in schizophrenia and schizoaffective disorder study. Psychiatry Res. 2020; 113346:1–13.
Article
39. Hanssen E, Balvert S, Borkelmans K, van Os J, Delespaul P, et al. An ecological momentary intervention incorporating personalised feedback to improve symptoms and social functioning in schizophrenia spectrum disorders. Psychiatry Res. 2020; 112695:1–8.
Article
40. Hui CLM, Lam BST, Wong AKH, Tao TJ, Ho ECN, Suen YN, et al. ReMind, a smartphone application for psychotic relapse prediction: a longitudinal study protocol. Early Interv Psychiatry. 2021; 15:1659–1666.
Article
41. Lewis S, Ainsworth J, Sanders C, Stockton-Powdrell C, Machin M, Whelan P, et al. Smartphone-enhanced symptom management in psychosis: Open, randomized controlled trial. J Med Internet Res. 2020; 8:1–11.
Article
42. Traber-Walker N, Gerstenberg M, Metzler S, Joris MR, Karr M, Studer N, et al. Evaluation of the combined treatment approach “robin”(Standardized Manual and Smartphone App) for adolescents at clinical high risk for psychosis. Front Psychiatry. 2019; 384:1–11.
43. Bell IH, Rossell SL, Farhall J, Hayward M, Lim MH, FieldingSmith SF, et al. Pilot randomised controlled trial of a brief copingfocused intervention for hearing voices blended with smartphonebased ecological momentary assessment and intervention (SAVVy): Feasibility, acceptability and preliminary clinical outcomes. Schizophr Res. 2020; 216:479–487.
Article
44. Vaessen T, Steinhart H, Batink T, Klippel A, Van Nierop M, Reininghaus U, et al. ACT in daily life in early psychosis: an ecological momentary intervention approach. Psychosis. 2019; 11:93–104.
Article
45. Nicholson J, Wright SM, Carlisle AM. Pre-post, mixed-methods feasibility study of the WorkingWell mobile support tool for individuals with serious mental illness in the USA: a pilot study protocol. BMJ Open. 2018; 2:1–9.
Article
46. Terp M, Jørgensen R, Laursen BS, Mainz J, Bjørnes CD. A smartphone app to foster power in the everyday management of living with schizophrenia: Qualitative analysis of young adults’ perspectives. JMIR Ment Health;2018.
47. Biagianti B, Hidalgo-Mazzei D, Meyer N. Developing digital interventions for people living with serious mental illness: Perspectives from three mHealth studies. Evid Based Ment Health. 2017; 20:98–101.
Article
48. Garety P, Ward T, Emsley R, Greenwood K, Freeman D, Fowler D, et al. Digitally supported CBT to reduce paranoia and improve reasoning for people with schizophrenia-spectrum psychosis: the SlowMo RCT. Efficacy and Mech Eval. 2021; 8:1–90.
Article